Gene therapy for disorders such as amyotrophic lateral sclerosis, Parkinson’s disease and Batten disease has seen success in animal models.
Browsing: Cognitive/neurodegenerative disorders
Largest study of its kind reveals that the appendix could act as a reservoir for disease-associated proteins related to Parkinson’s disease.
In a Phase III clinical trial, a novel drug termed GV-971 has shown promise for improving cognition in people with mild-to-moderate Alzheimer’s disease.
More evidence reported for causal link between herpes viruses and Alzheimer’s; reinvigorating research into the possible role of infections – and their treatment – in the disease.
Researchers from Tufts University have developed 3D human tissue culture models for the CNS. This may facilitate the discovery of new treatment methods for neurodegenerative diseases.
Digital brain simulates patterns of atrophy associated with neurodegenerative diseases through altering the initial starting zone of toxic proteins.
A pioneering treatment, an antibody termed PRN100, is to be given to a patient with sporadic Creutzfeldt-Jakob disease for the first time.
Chinese tech firm Tencent and British healthcare technology company Medopad are joining forces to develop an artificial intelligence model with the ability to assess motor function in patients with Parkinson’s disease.
A recent study indicates that a chronic periodontal pathogen infection could result in the development of Alzheimer’s disease.